Drugs / Xiang Sha Liu Jun Zi Decoction
Trials 1
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Phase 4 | NCT04562428 | Nov → Dec 2020 | hepatocellular carcinoma | China Medical University Hospital | Completed | No outcome recorded |
Evidence & citations 3 cited values
Every value below carries the sentence it was read from. 1 source stands behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | Xiang Sha Liu Jun Zi Decoction | ClinicalTrials.gov intervention name — accepted as the source's own label NCT04562428 ↗ |
| Known as | XSLJZ | “The purpose of the study was search the safety and efficacy of the of Xiang Sha Liu Jun Zi Decoction (XSLJZ) in advanced hepatocellular carcinoma patients with multiple protein...” NCT04562428 ↗ |
| Modality | Traditional medicine (herbal / TCM) | “traditional Chinese medicine treatment” NCT04562428 ↗ |